Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 12 , Pages 1375-1383 , December 2008

Methylphenidate and Amphetamine Do Not Induce Cytogenetic Damage in Lymphocytes of Children With ADHD

,Accepted 3 July 2008.

References 

  1. Safer DJ . Are stimulants overprescribed for youths with ADHD? . Ann Clin Psychiatry . 2000;12:55–62
  2. Safer DJ , Malever M . Stimulant treatment in Maryland public schools . Pediatrics . 2000;106:533–539
  3. Zito JM , Safer DJ , dosReis S , Magder LS , Gardner JF , Zarin DA . Psychotherapeutic medication patterns for youths with attention-deficit/hyperactivity disorder . Arch Pediatr Adolesc Med . 1999;153:1257–1263
  4. Zito JM , Safer DJ , dosReis S , Gardner JF , Boles M , Lynch F . Trends in the prescribing of psychotropic medications to preschoolers . JAMA . 2000;283:1025–1030
  5. Castle L , Aubert RE , Verbrugge RR , Khalid M , Epstein RS . Trends in medication treatment for ADHD . J Atten Disord . 2007;10:335–342
  6. Dulcan MK , Benson RS . AACAP Official Action. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD . J Am Acad Child Adolesc Psychiatry . 1997;36:1311–1317
  7. Biederman J , Spencer TJ , Wilens TE , Prince JB , Faraone SV . Treatment of ADHD with stimulant medications: response to Nissen perspective in the New England Journal of Medicine . J Am Acad Child Adolesc Psychiatry . 2006;45:1147–1150
  8. Donner R , Michaels MA , Ambrosini PJ . Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder . Biol Psychiatry . 2007;61(5):706–712
  9. Faraone SV . Stimulant therapy in the management of ADHD: mixed amphetamine salts (extended release) . Expert Opin Pharmacother . 2007;8:2127–2134
  10. Greenhill LL , Halperin JM , Abikoff H . Stimulant medications . J Am Acad Child Adolesc Psychiatry . 1999;38:503–512
  11. Nissen SE . ADHD drugs and cardiovascular risk . N Engl J Med . 2006;354:1445–1448
  12. El-Zein RA , Abdel-Rahman SZ , Hay MJ , et al.   Cytogenetic effects in children treated with methylphenidate . Cancer Lett . 2005;230:284–291
  13. Bonassi S , Znaor A , Norppa H , Hagmar L . Chromosomal aberrations and risk of cancer in humans: an epidemiologic perspective . Cytogenet Genome Res . 2004;104:376–382
  14. Bonassi S , Znaor A , Ceppi M , et al.   An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans . Carcinogenesis . 2007;28:625–631
  15. Preston RJ , Kollins SH , Swanson JM , et al.   Comments on ‘Cytogenetic effects in children treated with methylphenidate’ by El-Zein et al . Cancer Lett . 2005;230:292–294
  16. El-Zein RA , Hay MJ , Lopez MS , et al.   Response to comments on ‘Cytogenetic effects in children treated with methylphenidate’ by El-Zein et al . Cancer Lett . 2006;231(1):146–148
  17. Mortelmans K , Haworth S , Lawlor T , Speck W , Tainer B , Zeiger E . Salmonella mutagenicity tests: II. Results from the testing of 270 chemicals . Environ Mutagen . 1986;8(Suppl 7):1–119
  18. Galloway SM , Armstrong MJ , Reuben C , et al.   Chromosome aberrations and sister chromatid exchanges in Chinese hamster ovary cells: evaluations of 108 chemicals . Environ Mol Mutagen . 1987;10(Suppl 10):1–175
  19. Teo SK , San RH , Wagner VO , et al.   D-Methylphenidate is non-genotoxic in in vitro and in vivo assays . Mutat Res . 2003;537:67–79
  20. National Toxicology Program  . Toxicology and Carcinogenesis Studies of Methylphenidate Hydrochloride (CAS no. 298-59-9) in F344/N Rats and B6C3F1 Mice (Feed studies). Technical Report Series No. 439. U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health . Research Triangle Park: U.S. Department of Health and Human Services; 1995;
  21. Suter W , Martus HJ , Elhajouji A . Methylphenidate is not clastogenic in cultured human lymphocytes and in the mouse bone-marrow micro-nucleus test . Mutat Res . 2006;607:153–159
  22. Walitza S , Werner B , Romanos M , Warnke A , Gerlach M , Stopper H . Does methylphenidate cause a cytogenetic effect in children with attention deficit hyperactivity disorder? . Environ Health Perspect . 2007;115:936–940
  23. Jacobson-Kram D , Mattison D , Shelby M , Slikker W , Tice R , Witt K . Methylphenidate and chromosome damage . Cancer Lett . 2008;260:216–218
  24. American Psychiatric Association  . Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR . 4th ed.. Washington: American Psychiatric Association; 2000;
  25. Dulcan M . Practice parameters for the assessment and treatment of children, adolescents, and adults with attention-deficit/hyper-activity disorder. American Academy of Child and Adolescent Psychiatry . J Am Acad Child Adolesc Psychiatry . 1997;36(Suppl 10):85S–121S
  26. American Academy of Pediatrics  . Clinical practice guideline: diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder . Pediatrics . 2000;105:1158–1170
  27. Conners CK . Conners Rating Scales—Revised. Technical Manual . North Tonawanda: Multi-Health Systems; 1997;
  28. Shaffer D , Fisher P , Lucas CP , Dulcan MK , Schwab-Stone ME . NIMH Diagnostic Interview Schedule for Children Version IV (NIMH DISC-IV): description, differences from previous versions, and reliability of some common diagnoses . J Am Acad Child Adolesc Psychiatry . 2000;39:28–38
  29. FDA Guidelines, Good Laboratory Practice, Part 58. Title 21. Code of Federal Regulations.
  30. Conover WJ . Practical Nonparametric Statistics . New York: John Wiley & Sons; 1971;
  31. Bender MA , Preston RJ , Leonard RC , Pyatt BE , Gooch PC . Chromosomal aberration and sister-chromatid exchange frequencies in peripheral blood lymphocytes of a large human population sample. II. Extension of age range . Mutat Res . 1989;212:149–154
  32. Neri M , Ceppi M , Knudsen LE , et al.   Baseline micronuclei frequency in children: estimates from meta- and pooled analyses . Environ Health Perspect . 2005;113:1226–1229
  33. Volkow ND , Insel TR . What are the long-term effects of methylphenidate treatment? . Biol Psychiatry . 2003;54:1307–1309
  34. Lambert NM , Hartsough CS . Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants . J Learn Disabil . 1998;31:533–544
  35. Mick E , Biederman J , Faraone SV . Comment on Lambert and Hartsough (1998) . J Learn Disabil . 2000;33:314; author reply 314–316.
  36. Oestreicher N , Friedman GD , Jiang SF , Chan J , Quesenberry C , Habel LA . Methylphenidate use in children and risk of cancer at 18 sites: results of surveillance analyses . Pharmacoepidemiol Drug Saf . 2007;16:1268–1272
  37. Selby JV , Friedman GD , Fireman BH . Screening prescription drugs for possible carcinogenicity: eleven to fifteen years of follow-up . Cancer Res . 1989;49:5736–5747
  38. Wu EQ , Birnbaum HG , Zhang HF , Ivanova JI , Yang E , Mallet D . Health care costs of adults treated for attention-deficit/hyperactivity disorder who received alternative drug therapies . J Manag Care Pharm . 2007;13:561–569
  39. Witt KL , Cunningham CK , Patterson KB , et al.   Elevated frequencies of micronucleated erythrocytes in infants exposed to zidovudine in utero and postpartum to prevent mother-to-child transmission of HIV . Environ Mol Mutagen . 2007;48:322–329

 This research was supported by the NIH/NICHD Best Pharmaceuticals for Children Act pediatric drug development program and the Intramural Research Program of the National Toxicology Program of the National Institute of Environmental Health Sciences.The authors thank Dr. Gregory Erexson, George Stojhovic, and Kelley Boyer for establishing, coordinating, and conducting the cytogenic analysis. The authors also thank the Duke ADHD Program psychologists for help in recruitment and enrollment, the Program's clinical trials team for assistance with the evaluation process during the screening period, and the Program's research assistants for invaluable help in the conduct of the study. The authors also thank Drs. Raymond Tice and Andrew Kligerman for fruitful discussions during preparation of this manuscript.Clinical trial registration information—Genetic Measurements in Blood Cells of Children Taking Adderall or Methylphenidate. URL: http://clinicaltrials.gov. Unique identifier: NCT00341029.

PII: S0890-8567(08)60136-7

doi: 10.1097/CHI.0b013e3181893620

Journal of the American Academy of Child & Adolescent Psychiatry
Volume 47, Issue 12 , Pages 1375-1383 , December 2008

Article Tools

* Image Usage & Resolution